These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 18357751)

  • 21. Mechanisms of protection against simian immunodeficiency virus infection.
    Johnson RP
    Vaccine; 2002 May; 20(15):1985-7. PubMed ID: 11983259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Theory for prophylactic AIDS vaccine development].
    Nomura T; Matano T
    Uirusu; 2009 Dec; 59(2):267-75. PubMed ID: 20218335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of prophylactic AIDS vaccines: the current state of affairs.
    Hanke T
    Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new approach to AIDS research and prevention: the use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines.
    Haga T; Kuwata T; Ui M; Igarashi T; Miyazaki Y; Hayami M
    Microbiol Immunol; 1998; 42(4):245-51. PubMed ID: 9623910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.
    Gardner MB
    Antiviral Res; 1991 May; 15(4):267-86. PubMed ID: 1659310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection.
    O'Connor D; Friedrich T; Hughes A; Allen TM; Watkins D
    Immunol Rev; 2001 Oct; 183():115-26. PubMed ID: 11782252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in the development of an HIV-1 vaccine.
    Letvin NL
    Science; 1998 Jun; 280(5371):1875-80. PubMed ID: 9632379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of studying T cell responses in SIV-infected rhesus macaques.
    Valentine LE; Watkins DI
    Trends Microbiol; 2008 Dec; 16(12):605-11. PubMed ID: 18964016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS.
    Shearer GM; Pinto LA; Clerici M
    Immunol Today; 1999 Feb; 20(2):66-71. PubMed ID: 10098324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection.
    Geretti AM; Hulskotte E; Osterhaus AD
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818
    [No Abstract]   [Full Text] [Related]  

  • 31. [Development of HIV vaccines].
    Shibata R
    Nihon Rinsho; 2002 Apr; 60(4):790-7. PubMed ID: 11968790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analytic and integrative perspectives for HIV vaccine design].
    Yamamoto H
    Uirusu; 2013; 63(2):219-32. PubMed ID: 25366056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rationale for immunotherapy in HIV-1 infection.
    Walker BD
    J Acquir Immune Defic Syndr (1988); 1994; 7 Suppl 1():S6-13. PubMed ID: 8182510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New paradigms for HIV/AIDS vaccine development.
    Picker LJ; Hansen SG; Lifson JD
    Annu Rev Med; 2012; 63():95-111. PubMed ID: 21942424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward an AIDS vaccine.
    Walker BD; Burton DR
    Science; 2008 May; 320(5877):760-4. PubMed ID: 18467582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of HIV replication and future HIV therapy].
    Takeuchi H; Matano T
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):947-52. PubMed ID: 21089522
    [No Abstract]   [Full Text] [Related]  

  • 37. [Virological and immunological bases for HIV-1 vaccine design].
    Yamamoto H; Matano T
    Uirusu; 2007 Dec; 57(2):133-9. PubMed ID: 18357751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HIV adaptive immunity: determinants for viral persistence.
    Yamamoto H; Matano T
    Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus.
    Letvin NL; Schmitz JE; Jordan HL; Seth A; Hirsch VM; Reimann KA; Kuroda MJ
    Immunol Rev; 1999 Aug; 170():127-34. PubMed ID: 10566147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macaque models for AIDS vaccine development.
    Johnson RP
    Curr Opin Immunol; 1996 Aug; 8(4):554-60. PubMed ID: 8794019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.